Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
about
Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-αA new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome.Distinct features in natural history and outcomes of acute hepatitis C.Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.Clinical significance of the detection of antinuclear antibodies in patients with acute hepatitis a.Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.ANA testing in the presence of acute and chronic infections.Anti-ENA antibody profiles in patients with hepatitis C virus infection.The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.Natural history of vertically acquired HCV infection and associated autoimmune phenomena.Severe neutropenia in patients with chronic hepatitis C: a benign condition.SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.
P2860
Q28483978-27F8D85F-1DB8-4A8B-AD88-AC52F052C0EAQ33916375-6A8B38F4-EBD2-4D55-B620-C7375408282AQ33955210-BED5FFB7-4D1E-48F3-A673-DCB4AB8AEAAEQ34626547-E2E762DE-DB97-4BFE-B346-031CF6C559D0Q34827471-2D97C75C-BA22-4208-97D3-E7859700466FQ35195460-40BEB147-3E86-4ACB-93F8-591644769E12Q36231193-45DCC4A8-F891-4646-9B5E-17B64DDB027AQ36979114-A1076A3B-445D-4F6E-827E-483213C23E16Q38497449-9F0A9B97-8B35-4235-95E2-31AE8170A809Q38799673-486FCEDE-A41A-41E8-9734-DD2627F3E9E3Q40163497-DD76CD66-8EDB-4B65-AB25-DAFD14419BA1Q40526929-AA4F37D3-B259-4802-91AB-7635D4AA0131Q42226319-028753E6-8436-4C8F-B7F6-20D5B37F704CQ44432957-BC8C5681-12A6-4B3F-85DB-3685E0E74E4CQ47129673-9FBECEEB-E9D1-4787-B563-0D2C7024E71BQ55027429-6FF8CBD1-9E3A-4204-851A-73DFC5448349
P2860
Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Autoantibodies in chronic hepa ...... ociation with disease profile.
@en
Autoantibodies in chronic hepa ...... ociation with disease profile.
@nl
type
label
Autoantibodies in chronic hepa ...... ociation with disease profile.
@en
Autoantibodies in chronic hepa ...... ociation with disease profile.
@nl
prefLabel
Autoantibodies in chronic hepa ...... ociation with disease profile.
@en
Autoantibodies in chronic hepa ...... ociation with disease profile.
@nl
P2093
P1476
Autoantibodies in chronic hepa ...... ociation with disease profile.
@en
P2093
M J Williams
Trent HCV Group
W L Irving
P304
P356
10.1111/J.1365-2893.2008.01035.X
P577
2009-03-03T00:00:00Z